Saturday, November 21, 2026

REMEDI's Miniature X-Ray Sells More Than 2,200 Units in India; Government Names It a 'World-Class Product'

Input
2026-11-19 15:13:16
Updated
2026-11-19 15:13:16
Cho Bong-ho, CEO of REMEDI (right), poses for a commemorative photo after the awards ceremony at the '2026 World-Class Product' event held at LOTTE HOTEL WORLD in Seoul on the 17th. Courtesy of REMEDI.

[Financial News]  South Korean medical imaging company REMEDI is stepping up efforts to expand its overseas business, building on its supply track record in the public healthcare markets of India and the Philippines. Its strategy is to target government procurement markets in emerging economies with miniature X-ray equipment that medical staff can carry themselves, rather than large, fixed hospital equipment.
According to the medical device industry on the 19th, REMEDI's miniature portable X-ray system, 'REMEX-KA6,' was selected as a '2026 World-Class Product,' a program overseen by the Ministry of Trade, Industry and Energy. At a certificate presentation ceremony held at LOTTE HOTEL WORLD in Seoul on the 17th, REMEDI was certified as a producer of a Current World-Class Product.
The 'World-Class Product' program is a government certification scheme for products that rank among the top five in global market share or hold at least 5% of the market. REMEDI was newly recognized as a producer of a Current World-Class Product in the portable X-ray generator category. Of particular note is its supply track record in overseas public healthcare markets. Through a government procurement project related to India's National Tuberculosis Elimination Program (NTEP), REMEDI supplied 1,534 KA6 units last year. It delivered about 750 more in the first half of this year, bringing cumulative supplies to around 2,284 units.
Demand for portable X-rays has risen as the Indian government expands mobile tuberculosis screening, particularly in rural and farming and fishing communities with limited medical infrastructure. REMEDI is broadening its foothold in the government procurement market by supplying equipment to local public healthcare institutions.
REMEDI is also building a business base in the Philippines. According to the company, the KA6 has been deployed in local tuberculosis screening programs and used to screen about 120,000 people over the past year. This month, it also completed registration as a Class C medical device with the Philippine Food and Drug Administration (FDA). This lays the regulatory groundwork for future government tenders and expanded supplies to public healthcare institutions.
The KA6 is a portable X-ray device weighing about 2.4 kg. Designed to take at least 250 images on a single charge, it can be used even in areas with limited electricity and medical facilities. Unlike conventional imaging equipment centered in hospitals, it can be used for mobile screening and in disaster and emergency medical settings.
The certification is also expected to help expand overseas sales channels. Producers of World-Class Products receive benefits such as overseas marketing support from the Korea Trade-Investment Promotion Agency (KOTRA), export insurance and guarantees, and preferential financing.
REMEDI is also pursuing the integration of its miniature X-ray generator technology with artificial intelligence (AI)-based medical imaging solutions. The company plans to increase supply volumes in overseas government procurement markets while expanding into medical imaging diagnostics.
The medical device industry sees the competitiveness of the portable X-ray market as depending not only on equipment miniaturization but also on overseas government tender performance and local maintenance capabilities. Analysts say public healthcare procurement can lead to additional orders and equipment replacement demand after initial supply, making it important to establish a long-term business base.
A REMEDI representative emphasized, "We plan to strengthen our competitiveness in the global public healthcare market by combining miniature X-ray technology with AI-based medical imaging solutions."
[email protected] Kim Gyeong-a Reporter